Could a safer scan replace standard CT for testicular cancer Follow-Up?

NCT ID NCT03142802

Ongoing Diagnosis Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether low-dose CT scans can detect testicular cancer recurrence as well as standard CT scans, but with much less radiation. About 251 men with stage I testicular cancer will be monitored using low-dose CT. If it works, patients could avoid the long-term risks of repeated radiation from standard scans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-dose computed tomography (LDCT)
What this could lead to: If successful, this could make routine cancer surveillance safer by reducing radiation exposure without missing recurrences.
What could go wrong: This is a mid-stage study with 251 participants, so results may not apply to everyone. Low-dose scans might miss small recurrences or produce more false alarms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE I TESTICULAR GERM CELL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant testicular germ cell tumor testicular cancer testicular germ cell tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TESTICULAR CANCER

Contacts and locations

Locations

University Health Network, Princess Margaret Hospital

Toronto, Ontario, M5G 2M9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.